| Systematic (IUPAC) name | |
|---|---|
| 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Not Currently Scheduled |
| Identifiers | |
| CAS number | 2201-35-6 91164-58-8 (hydrochloride) |
| ATC code | None |
| PubChem | CID 11778080 |
| ChemSpider | 10526416 |
| Chemical data | |
| Formula | C18H27NO |
| Mol. mass | 273.412 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
4-Methoxyphencyclidine (methoxydine, 4-MeO-PCP) is a dissociative anesthetic drug with hallucinogenic and sedative effects. Its dissociative effects are comparable to ketamine, but has slightly different effects due to its altered binding profile at various targets, particularly being significantly more potent as an NMDA antagonist while having around the same potency as a dopamine reuptake inhibitor.[1][2][3][4]
The positional isomer 3-MeO-PCP is also known. Being around 5 times more potent by weight than the 4-methoxy isomer it has around the same potency as PCP. 4-Meo-PCP was reportedly first sold within the UK from 2008 as a designer drug and research chemical by a company trading under the name CBAY.[5]
|
||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
| This psychedelics, dissociatives and deliriants-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)